Successful Dose De-Escalation to Adalimumab 40 mg Every Three Weeks in Patients with Crohn's Disease

Autor:	Severine Vermeire, Sophie Van Steenbergen, Gert A. Van Assche, Ann Gils, Vera Ballet, Sumin Bian, Marc Ferrante
Rok vydání:	2017
Předmět:	medicine.medical_specialty Crohn's disease Hepatology business.industry Gastroenterology medicine.disease Internal medicine medicine Adalimumab Every Three Weeks In patient business De-escalation medicine.drug
Zdroj:	Gastroenterology. 152:S406-S407
ISSN:	0016-5085
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c5222523acc3b52789f043a8e20602e5 https://doi.org/10.1016/s0016-5085(17)31590-1 Zobrazit plný text záznamu